Health Canada gives Moderna vaccine trial clearance for Ebola species tied to Congo outbreak
By {}
The Globe and Mail - Canada · 4d ago

Originally published by The Globe and Mail - Canada.
By {}
The Globe and Mail - Canada · 4d ago

Originally published by The Globe and Mail - Canada.
The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.
Global News - Health · 2d ago
Outbreak declared on May 15,has been linked to the Bundibugyo virus for which there are no approved vaccines or treatments
The Globe and Mail - World · 4d ago
Program lets patients bypass their doctor and privately book diagnostic imaging
The Globe and Mail - Canada · 1d ago
Prosecutors are expected to wrap up their case Friday in the trial of a man accused of killing his nine-year-old daughter last summer during a trip to New York.
Global News - Canada · 1d ago
Advertisement
Venture Together
Business finance for operators who need capital that moves with the company.
SME lending for single-owner businesses — working capital, growth and equipment from £10,000 to £500,000.
Representative APR 5.9%. Lending subject to status.